Goldman Sachs suggests that Biotech offers untapped potential for investors seeking benefits from lower interest rates

Biotech is an overlooked way to benefit from lower rates, Goldman says

Investing in Biotech Stocks: A Hidden Opportunity Ahead of the Federal Reserve Rate Decision As investors eagerly await the Federal Reserve rate decision, there is a group of stocks that often goes overlooked but could … Read more